Literature DB >> 17496021

Specific adsorption of osteopontin and synthetic polypeptides to calcium oxalate monohydrate crystals.

Adam Taller1, Bernd Grohe, Kem A Rogers, Harvey A Goldberg, Graeme K Hunter.   

Abstract

Protein-crystal interactions are known to be important in biomineralization. To study the physicochemical basis of such interactions, we have developed a technique that combines confocal microscopy of crystals with fluorescence imaging of proteins. In this study, osteopontin (OPN), a protein abundant in urine, was labeled with the fluorescent dye AlexaFluor-488 and added to crystals of calcium oxalate monohydrate (COM), the major constituent of kidney stones. In five to seven optical sections along the z axis, scanning confocal microscopy was used to visualize COM crystals and fluorescence imaging to map OPN adsorbed to the crystals. To quantify the relative adsorption to different crystal faces, fluorescence intensity was measured around the perimeter of the crystal in several sections. Using this method, it was shown that OPN adsorbs with high specificity to the edges between {100} and {121} faces of COM and much less so to {100}, {121}, or {010} faces. By contrast, poly-L-aspartic acid adsorbs preferentially to {121} faces, whereas poly-L-glutamic acid adsorbs to all faces approximately equally. Growth of COM in the presence of rat bone OPN results in dumbbell-shaped crystals. We hypothesize that the edge-specific adsorption of OPN may be responsible for the dumbbell morphology of COM crystals found in human urine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17496021      PMCID: PMC1948058          DOI: 10.1529/biophysj.106.101881

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  38 in total

1.  Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily.

Authors:  H Shiraga; W Min; W J VanDusen; M D Clayman; D Miner; C H Terrell; J R Sherbotie; J W Foreman; C Przysiecki; E G Neilson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

2.  Interactions between acidic proteins and crystals: stereochemical requirements in biomineralization.

Authors:  L Addadi; S Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

3.  Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications.

Authors:  Brian Christensen; Mette S Nielsen; Kim F Haselmann; Torben E Petersen; Esben S Sørensen
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

4.  Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals.

Authors:  J R Hoyer; J R Asplin; L Otvos
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

Review 5.  Osteopontin and calcium stone formation.

Authors:  Jack G Kleinman; Jeffrey A Wesson; Jeremy Hughes
Journal:  Nephron Physiol       Date:  2004

6.  Methodological aspects of spontaneous crystalluria studies in calcium stone formers.

Authors:  C A Bader; A Chevalier; C Hennequin; P Jungers; M Daudon
Journal:  Scanning Microsc       Date:  1994

7.  Morphological effects of glycosaminoglycans on calcium oxalate monohydrate crystals.

Authors:  Y Shirane; Y Kurokawa; Y Sumiyoshi; S Kagawa
Journal:  Scanning Microsc       Date:  1995

8.  Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects.

Authors:  F Atmani; P A Glenton; S R Khan
Journal:  Urol Res       Date:  1998

9.  Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro.

Authors:  S R Rittling; H N Matsumoto; M D McKee; A Nanci; X R An; K E Novick; A J Kowalski; M Noda; D T Denhardt
Journal:  J Bone Miner Res       Date:  1998-07       Impact factor: 6.741

10.  Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules.

Authors:  Jeffrey A Wesson; Richard J Johnson; Marrilda Mazzali; Anne M Beshensky; Susan Stietz; Ceci Giachelli; Lucy Liaw; Charles E Alpers; William G Couser; Jack G Kleinman; Jeremy Hughes
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

View more
  14 in total

1.  MMS6 protein regulates crystal morphology during nano-sized magnetite biomineralization in vivo.

Authors:  Masayoshi Tanaka; Eri Mazuyama; Atsushi Arakaki; Tadashi Matsunaga
Journal:  J Biol Chem       Date:  2010-12-18       Impact factor: 5.157

2.  Incorporation of osteopontin peptide into kidney stone-related calcium oxalate monohydrate crystals: a quantitative study.

Authors:  Jared S Gleberzon; Yinyin Liao; Silvia Mittler; Harvey A Goldberg; Bernd Grohe
Journal:  Urolithiasis       Date:  2018-12-19       Impact factor: 3.436

3.  Cooperation of phosphates and carboxylates controls calcium oxalate crystallization in ultrafiltered urine.

Authors:  Bernd Grohe; Brian P H Chan; Esben S Sørensen; Gilles Lajoie; Harvey A Goldberg; Graeme K Hunter
Journal:  Urol Res       Date:  2011-01-14

4.  Face-specific incorporation of osteopontin into urinary and inorganic calcium oxalate monohydrate and dihydrate crystals.

Authors:  Lauren A Thurgood; Alison F Cook; Esben S Sørensen; Rosemary L Ryall
Journal:  Urol Res       Date:  2010-07-22

5.  Microstructures of Randall's plaques and their interfaces with calcium oxalate monohydrate kidney stones reflect underlying mineral precipitation mechanisms.

Authors:  Ingo Sethmann; Gunnar Wendt-Nordahl; Thomas Knoll; Frieder Enzmann; Ludwig Simon; Hans-Joachim Kleebe
Journal:  Urolithiasis       Date:  2016-10-01       Impact factor: 3.436

6.  Prevention of water contamination of ethanol-saturated dentin and hydrophobic hybrid layers.

Authors:  Salvatore Sauro; Timothy F Watson; Francesco Mannocci; Franklin R Tay; David H Pashley
Journal:  J Adhes Dent       Date:  2009-08       Impact factor: 2.359

Review 7.  Biomolecular mechanism of urinary stone formation involving osteopontin.

Authors:  Kenjiro Kohri; Takahiro Yasui; Atsushi Okada; Masahito Hirose; Shuzo Hamamoto; Yasuhiro Fujii; Kazuhiro Niimi; Kazumi Taguchi
Journal:  Urol Res       Date:  2012-11-06

8.  Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning.

Authors:  Yung-Ching Chien; David L Masica; Jeffrey J Gray; Sarah Nguyen; Hojatollah Vali; Marc D McKee
Journal:  J Biol Chem       Date:  2009-07-06       Impact factor: 5.157

9.  Face-specific binding of prothrombin fragment 1 and human serum albumin to inorganic and urinary calcium oxalate monohydrate crystals.

Authors:  Alison F Cook; Phulwinder K Grover; Rosemary L Ryall
Journal:  BJU Int       Date:  2008-11-13       Impact factor: 5.588

10.  Cementomimetics-constructing a cementum-like biomineralized microlayer via amelogenin-derived peptides.

Authors:  Mustafa Gungormus; Ersin E Oren; Jeremy A Horst; Hanson Fong; Marketa Hnilova; Martha J Somerman; Malcolm L Snead; Ram Samudrala; Candan Tamerler; Mehmet Sarikaya
Journal:  Int J Oral Sci       Date:  2012-06-29       Impact factor: 6.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.